EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieStudienprotokollOpen Access

Brief cognitive-behavioral treatment for avoidant/restrictive food intake disorder in the context of functional dyspepsia: Study protocol for a feasibility randomized controlled trial

Helen Burton Murray, Brjánn Ljótsson, Brian Healy, Lukas Van Oudenhove, Jonathan S Williams, Laurie Keefer, Elizabeth A Lawson, Braden Kuo, Jennifer J Thomas

Contemporary Clinical Trials · 2023

DOI: 10.1016/j.cct.2023.107336 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Contemporary Clinical Trials, 2023. Verfasst von Helen Burton Murray und 8 weiteren Autor:innen. Beteiligte Einrichtung: Harvard Medical School, Boston, MA, USA; Multidisciplinary Eating Disorders Research Collaborative, Mass General Brigham, Boston, MA, USA; Division o…. Hauptthemen laut MEDLINE: Avoidant Restrictive Food Intake Disorder, Dyspepsia, Feeding and Eating Disorders. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIMH NIH HHS, NIDDK NIH HHS, National Institute of Mental Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Avoidant/restrictive food intake disorder (ARFID) symptoms are common (up to 40%) among adults with functional dyspepsia (FD), a disorder of gut-brain interaction characterized by early satiation, post-prandial fullness, epigastric pain, and/or epigastric burning. Using an 8-session exposure-based cognitive-behavioral treatment (CBT) for adults with FD + ARFID compared to usual care (UC) alone, we aim to: (1) determine feasibility, (2) evaluate change in clinical outcomes in, and (3) explore possible mechanisms of action. METHODS: We will randomize adults with FD who meet criteria for ARFID with ≥5% weight loss (N = 50) in a 1:1 ratio to CBT (with continued UC) or to UC alone. A priori primary benchmarks will be: ≥75% eligible participants enroll; ≥75% participants complete assessments; ≥70% participants attend 6/8 sessions; ≥70% of sessions have all content delivered; ≥70% participants rate Client Satisfaction Questionnaire scores above scale midpoint. We will also examine the size of changes in FD symptom severity and related quality of life within and between groups, and explore possible mechanisms of action. CONCLUSIONS: Findings from this trial will inform next steps with treatment development or evaluation-either for further refinement or for next-step efficacy testing with a fully-powered clinical trial.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Avoidant Restrictive Food Intake DisorderDyspepsiaFeeding and Eating DisordersAdultHumansFeasibility StudiesQuality of LifeEatingCognitionRetrospective StudiesRandomized Controlled Trials as Topic

Stichwörter der Autor:innen

Avoidant/restrictive food intake disorderCognitive-behavioral therapyDisorders of gut-brain interactionFeasibilityFeeding and eating disordersFunctional dyspepsia

Autor:innen und Institutionen

  • Harvard Medical School, Boston, MA, USA; Multidisciplinary Eating Disorders Research Collaborative, Mass General Brigham, Boston, MA, USA; Division of Gastroenterology, Massachusetts General Hospital, Boston, MA, USA. E…
  • Department of Clinical Neuroscience, Division of Psychology, Karolinska Institutet, Stockholm, Sweden.
  • Harvard Medical School, Boston, MA, USA; Biostatistics Center, Massachusetts General Hospital, Boston, MA, USA.
  • Laboratory for Brain-Gut Axis Studies (LaBGAS), Translational Research in Gastrointestinal Disorders (TARGID), Department of Chronic Diseases and Metabolism (CHROMETA), KU Leuven, Leuven, Belgium; Leuven Brain Institute…
  • Harvard Medical School, Boston, MA, USA; Division of Endocrinology, Diabetes and Hypertension, Brigham and Women's Hospital, Boston, MA, USA.
  • Icahn School of Medicine at Mount Sinai, NY, New York, USA.

Förderung

  • NIMH NIH HHS
  • NIDDK NIH HHS
  • National Institute of Mental Health
  • National Institute of Diabetes and Digestive and Kidney Diseases

Zitieren

APA

Burton Murray, H., Ljótsson, B., Healy, B., Van Oudenhove, L., Williams, J. S., Keefer, L., Lawson, E. A., Kuo, B., & Thomas, J. J. (2023). Brief cognitive-behavioral treatment for avoidant/restrictive food intake disorder in the context of functional dyspepsia: Study protocol for a feasibility randomized controlled trial. Contemporary Clinical Trials. https://doi.org/10.1016/j.cct.2023.107336

Vancouver

Burton Murray H, Ljótsson B, Healy B, Van Oudenhove L, Williams JS, Keefer L, et al. Brief cognitive-behavioral treatment for avoidant/restrictive food intake disorder in the context of functional dyspepsia: Study protocol for a feasibility randomized controlled trial. Contemporary Clinical Trials. 2023. doi:10.1016/j.cct.2023.107336

BibTeX
@article{BurtonMurray2023,
  author = {Burton Murray, Helen and Ljótsson, Brjánn and Healy, Brian and Van Oudenhove, Lukas and Williams, Jonathan S and Keefer, Laurie and Lawson, Elizabeth A and Kuo, Braden and Thomas, Jennifer J},
  title = {Brief cognitive-behavioral treatment for avoidant/restrictive food intake disorder in the context of functional dyspepsia: Study protocol for a feasibility randomized controlled trial},
  journal = {Contemporary Clinical Trials},
  year = {2023},
  doi = {10.1016/j.cct.2023.107336}
}
Kostenlos starten →